Showing results (1091-1100 of 6,317) with videos related to

Sort By:
Pageof 632
Diabetes, Obesity & Metabolism|September 18, 2025
Empagliflozin for the preservation of beta-cell function in women with recent gestational diabetes: A randomized placebo-controlled trialShamini Murugavel, Ravi Retnakaran, Denice S Feig, et al.
Diabetes, Obesity & Metabolism|September 25, 2025
Boosting the engraftment of subcutaneously transplanted pancreatic islets by nanofatSelina Wrublewsky, Caroline Bickelmann, Lea Stefanie Meßmer, et al.
Diabetes, Obesity & Metabolism|September 22, 2025
Efficacy and safety of Efsubaglutide Alfa in "overrun" patients in the SUPER2 trial: A post-hoc analysis for comprehensive evaluationWeiping Jia, Fan Jiang, Yulong Xu, et al.
Diabetes, Obesity & Metabolism|August 19, 2025
Gender differences in the prescription of SGLT2 inhibitors in chronic kidney disease: A real-world database studyTatsuhiko Azegami, Hidehiro Kaneko, Akira Okada, et al.
Diabetes, Obesity & Metabolism|August 19, 2025
Dietary BCAA supplementation counteracts the beneficial effects of long-term aerobic exercise against obesity and associated metabolic disorders by suppressing FGF21 expressionJun Zhang, Xuejiao Zhang, Peiyuan Li, et al.
Diabetes, Obesity & Metabolism|August 14, 2025
Efficacy and safety of pioglitazone, empagliflozin and glimepiride as third-line agents in patients with type 2 diabetes inadequately controlled with metformin and DPP-4 inhibitors: A multicentre, phase 4 randomized controlled trialYun Kyung Cho, Jae-Hyoung Cho, Sang-Mo Hong, et al.
Diabetes, Obesity & Metabolism|September 10, 2025
An SGLT2 inhibitor, canagliflozin, reduces blood glucose level in the renal capillaries and protects the capillary network in the diabetic ratsAnqi Zhang, Zhicheng Bi, Satoshi Kidoguchi, et al.
Diabetes, Obesity & Metabolism|September 11, 2025
Sex differences in the efficacy of GLP-1 receptor agonists: A systematic review and meta-analysis of cardiovascular and renal outcome trialsHasan Fareed Siddiqui, Dua Ali, Maryam Sajid, et al.
Diabetes, Obesity & Metabolism|August 5, 2025
Real-world titration, persistence & weight loss of semaglutide and tirzepatide in an academic obesity clinicJason M Samuels, Fei Ye, Rebecca Irlmeier, et al.
Diabetes, Obesity & Metabolism|August 11, 2025
Ketosis and ketoacidosis in hospitalized patients receiving SGLT2 inhibitor therapyFrank M Gao, Kartik Kishore, Dinesh Pandey, et al.
Pageof 632